Brachytherapy for Prostate Cancer: A Systematic Review
Open Access
- 1 September 2009
- journal article
- review article
- Published by Hindawi Limited in Advances in Urology
- Vol. 2009, 1-11
- https://doi.org/10.1155/2009/327945
Abstract
Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate cancer because of excellent long-term treatment outcomes in low-, intermediate-, and high-risk patients. To a great extend due to patient lead advocacy for minimally invasive treatment options, high-quality prostate implants have become widely available in the US, Europe, and Japan. High-dose-rate (HDR) afterloading brachytherapy in the management of localised prostate cancer has practical, physical, and biological advantages over low-dose-rate seed brachytherapy. There are no free live sources used, no risk of source loss, and since the implant is a temporary procedure following discharge no issues with regard to radioprotection use of existing facilities exist. Patients with localized prostate cancer may benefit from high-dose-rate brachytherapy, which may be used alone in certain circumstances or in combination with external-beam radiotherapy in other settings. The purpose of this paper is to present the essentials of brachytherapies techniques along with the most important studies that support their effectiveness in the treatment of prostate cancer.Keywords
This publication has 63 references indexed in Scilit:
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007
- Androgen Deprivation Therapy Does Not Impact Cause-Specific or Overall Survival in High-Risk Prostate Cancer Managed With Brachytherapy and Supplemental External BeamInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Biochemical (prostate-specific antigen) relapse-free survival and toxicity after125I low-dose-rate prostate brachytherapyBJU International, 2006
- External-Beam Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2006
- Poorly Differentiated Prostate Cancer Treated With Radical Prostatectomy: Long-Term Outcome and Incidence of Pathological DowngradingJournal of Urology, 2006
- Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1–T2 prostate cancerRadiotherapy and Oncology, 2006
- Braquiterapia de baja tasa (I125) en el cáncer de próstata localizado: Resultados preliminares a 5 añosArchivos Espanoles de Urologia, 2005
- Predicting Recurrence After Radical Prostatectomy for Patients With High Risk Prostate CancerJournal of Urology, 2003
- Importance of Post-Implant Dosimetry in Permanent Prostate BrachytherapyEuropean Urology, 2002
- Use of Transrectal Ultrasound in Transperineal 125Iodine Seeding for Prostate Cancer: MethodologyJournal of Endourology, 1989